Concepedia

G. Quack

GQ

Statistics

Publications

31

Citations

3.2K

H-Index

24

Active since

1988

Affiliations

Merz (Germany)(Current)

MerLion Pharma (Germany)

Institute of Psychiatry and Neurology

University of Würzburg

Universidad de Alcalá

G. Quack is an author at Merz (Germany) specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

1988–2012

31

Publications

31

Glutamate in CNS disorders as a target for drug development: an update

Chris G. Parsons, Wojciech Danysz, G. Quack · Drug News & Perspectives · 1998 · 447 citations

, , +17

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

Chris G. Parsons, G. Quack, I. Bresink et al. · Neuropharmacology · 1995 · 312 citations

, , +10

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)

José Javier Miguel-Hidalgo, X.A. Alvarez, Ramón Cacabelos et al. · Brain Research · 2002 · 264 citations

, , +10

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

Wojciech Danysz, Chris G. Parsons, Hans Jörg Möbius et al. · Neurotoxicity Research · 2000 · 262 citations

, , +17

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.

Chris G. Parsons, Wojciech Danysz, G. Quack et al. · PubMed · 1997 · 193 citations

, , +17

1–5 of 31